Provided by Tiger Fintech (Singapore) Pte. Ltd.

Heartbeam Inc

1.81
-0.1400-7.18%
Pre-market: 1.900.0900+4.97%08:15 EDT
Volume:227.72K
Turnover:420.79K
Market Cap:61.04M
PE:-2.48
High:1.92
Open:1.90
Low:1.75
Close:1.95
Loading ...

BRIEF-Heartbeam Successfully Meets Clinical Endpoints In Pivotal Study For Its Groundbreaking 12-Lead ECG Synthesis Technology

Reuters
·
Yesterday

Heartbeam Successfully Meets Clinical Endpoints in Pivotal Study for Its Groundbreaking 12-Lead Ecg Synthesis Technology

THOMSON REUTERS
·
Yesterday

HeartBeam Successfully Meets Clinical Endpoints in Pivotal Study for its Groundbreaking 12-Lead ECG Synthesis Technology

Business Wire
·
Yesterday

BRIEF-HeartBeam And AccurKardia Announce Strategic Collaboration To Advance Cardiac Monitoring Innovation

Reuters
·
24 Apr

Heartbeam and Accurkardia Announce Strategic Collaboration to Advance Cardiac Monitoring Innovation

THOMSON REUTERS
·
24 Apr

HeartBeam Advances Cardiac Care with FDA Clearance and New Innovations

TIPRANKS
·
14 Mar

Heartbeam Inc reports results for the quarter ended December 31 - Earnings Summary

Reuters
·
14 Mar

HeartBeam Q4 2024 Adj EPS $(0.73) Misses $(0.19) Estimate

Benzinga
·
14 Mar

Heartbeam FY Basic EPS USD -0.73

THOMSON REUTERS
·
14 Mar

HeartBeam Reports Fourth Quarter and Full Year 2024 Results

Business Wire
·
14 Mar

Heartbeam Inc expected to post a loss of 19 cents a share - Earnings Preview

Reuters
·
12 Mar

HeartBeam to Participate at Upcoming Conferences in Dana Point, California, March 16-21, 2025

Business Wire
·
06 Mar

HeartBeam to Host Fourth Quarter Full Year 2024 Results Conference Call on Thursday, March 13, 2025 at 4:30 p.m. Eastern Time

Business Wire
·
27 Feb

Heartbeam Announces Exercise and Closing of Underwriter’s Over-Allotment Option for Public Offering of Common Stock

THOMSON REUTERS
·
26 Feb

HeartBeam Announces Exercise and Closing of Underwriter’s Over-Allotment Option for Public Offering of Common Stock

Business Wire
·
26 Feb

Heartbeam Announces Pricing of $10.0 Million Underwritten Public Offering of Common Stock

THOMSON REUTERS
·
13 Feb

HeartBeam Announces Pricing of $10.0 Million Underwritten Public Offering of Common Stock

Business Wire
·
13 Feb

Heartbeam : Submitted a 510(K) Application to U.S. FDA for Co's 12-Lead Electrocardiogram (Ecg) Synthesis Software

THOMSON REUTERS
·
29 Jan

HeartBeam Achieves Major Milestone with FDA Submission for its Groundbreaking 12-Lead ECG Synthesis Software

Business Wire
·
29 Jan

HeartBeam to Attend JP Morgan 2025 Annual Healthcare Conference

Business Wire
·
23 Dec 2024